Moreover, SCD1 may be an autophagy-related protein in non-small cell lung cancer, and the combination therapy of autophagy inhibition and SCD1 inhibition could achieve a synergistic antitumor effect in vitro and in vivo [17]. This evidence concerns the gene SCD and non-small cell lung carcinoma.